Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$683M |
| 2 |
Meta Platforms (Facebook)
META
|
+$553M |
| 3 |
RTX Corp
RTX
|
+$450M |
| 4 |
Eli Lilly
LLY
|
+$389M |
| 5 |
T-Mobile US
TMUS
|
+$386M |
Top Sells
| 1 |
Amazon
AMZN
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Gilead Sciences
GILD
|
+$467M |
| 4 |
Merck
MRK
|
+$368M |
| 5 |
Intel
INTC
|
+$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
1326
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $12.6M | 0.01% |
211,515
+62,935
| +42% | +$3.76M |
|
1327
Laureate Education
LAUR
$4.33B
| $12.6M | 0.01% |
1,268,853
+64,973
| +5% | +$647K |
|
1328
SiriusPoint
SPNT
$2.22B
| $12.6M | 0.01% |
1,675,481
+52,099
| +3% | +$391K |
|
1329
Rithm Capital
RITM
$6.57B
| $12.6M | 0.01% |
1,692,369
+295,324
| +21% | +$2.19M |
|
1330
Stride
LRN
$6.91B
| $12.6M | 0.01% |
460,807
-251,944
| -35% | -$6.86M |
|
1331
Nektar Therapeutics
NKTR
$926M
| $12.5M | 0.01% |
36,112
-2,486
| -6% | -$864K |
|
1332
Tapestry
TPR
$22.2B
| $12.5M | 0.01% |
943,265
+128,533
| +16% | +$1.71M |
|
1333
National Health Investors
NHI
$3.72B
| $12.5M | 0.01% |
228,025
-224,744
| -50% | -$12.3M |
|
1334
Calavo Growers
CVGW
$489M
| $12.5M | 0.01% |
198,691
+3,699
| +2% | +$233K |
|
|
GBT
1335
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.5M | 0.01% |
197,985
-78,377
| -28% | -$4.95M |
|
|
BRSP
1336
BrightSpire Capital
BRSP
$764M
| $12.5M | 0.01% |
1,779,596
+250,887
| +16% | +$1.76M |
|
1337
Topgolf Callaway Brands
MODG
$1.76B
| $12.5M | 0.01% |
711,640
-69,087
| -9% | -$1.21M |
|
1338
Avis
CAR
$5.47B
| $12.5M | 0.01% |
544,331
+294,209
| +118% | +$6.73M |
|
1339
Unum
UNM
$12.8B
| $12.5M | 0.01% |
750,952
-14,145
| -2% | -$235K |
|
1340
Inspire Medical Systems
INSP
$2.37B
| $12.4M | 0.01% |
142,915
+77,488
| +118% | +$6.74M |
|
1341
OFG Bancorp
OFG
$1.95B
| $12.4M | 0.01% |
930,065
-104,231
| -10% | -$1.39M |
|
1342
Opko Health
OPK
$1.11B
| $12.4M | 0.01% |
3,646,179
+284,200
| +8% | +$969K |
|
1343
Kosmos Energy
KOS
$799M
| $12.4M | 0.01% |
7,477,283
+2,278,442
| +44% | +$3.78M |
|
1344
Toll Brothers
TOL
$13.8B
| $12.4M | 0.01% |
380,671
-39,260
| -9% | -$1.28M |
|
1345
Flowserve
FLS
$7.36B
| $12.4M | 0.01% |
434,808
+34,917
| +9% | +$996K |
|
1346
News Corp Class A
NWSA
$16.5B
| $12.3M | 0.01% |
1,035,032
-4,299
| -0.4% | -$51K |
|
1347
Bankunited
BKU
$2.96B
| $12.3M | 0.01% |
605,137
+254,313
| +72% | +$5.15M |
|
1348
LivePerson
LPSN
$86M
| $12.2M | 0.01% |
295,660
+25,950
| +10% | +$1.08M |
|
1349
Acuity Brands
AYI
$10.3B
| $12.2M | 0.01% |
127,399
-2,180
| -2% | -$209K |
|
|
MAGN
1350
Magnera Corporation
MAGN
$393M
| $12.2M | 0.01% |
58,425
-40
| -0.1% | -$8.35K |
|